Accelerated Clinical Trial Agreement Template for Germany

When time is critical in medical research, you need an agreement that can move quickly without compromising legal compliance or patient safety. An Accelerated Clinical Trial Agreement provides the legal framework for conducting expedited clinical research in Germany while adhering to all relevant EU and German regulatory requirements.

When do you need this document?

You'll need this agreement during public health emergencies such as pandemics, when testing breakthrough therapies for life-threatening conditions, or when conducting priority research for rare diseases with urgent medical need. Pharmaceutical companies use these agreements when regulatory authorities have granted fast-track designation or when emergency use authorization pathways are being pursued. The agreement is also essential when coordinating multi-site trials across Germany that require synchronized rapid deployment, or when working with Contract Research Organizations (CROs) on time-sensitive studies where standard timelines would delay potentially life-saving treatments.

Key legal considerations

Your agreement must address accelerated timelines while maintaining comprehensive liability protection and insurance coverage. Include provisions for expedited ethics committee reviews and streamlined documentation processes that still meet GCP standards. Establish clear protocols for enhanced safety monitoring and adverse event reporting that account for compressed study timelines. Address data protection requirements under GDPR with special attention to the rapid collection and processing of health data. Define modified milestone payments and performance metrics that reflect accelerated schedules, and include termination clauses that protect all parties if acceleration compromises patient safety or data integrity.

Legal requirements in Germany

Under German law, your accelerated clinical trial must comply with the EU Clinical Trials Regulation (EU) No 536/2014, which provides harmonized procedures for emergency situations. The German Medicines Act (AMG) requires that even accelerated trials maintain full regulatory oversight, including BfArM authorization where applicable. Your agreement must demonstrate compliance with German GCP-V regulations, ensuring that acceleration doesn't compromise trial quality or participant protection. Include specific provisions for expedited ethics committee procedures while maintaining full informed consent requirements. Address GDPR compliance with enhanced data processing agreements that account for the urgent nature of data collection and sharing. Ensure your insurance provisions meet German requirements for clinical trial coverage, including provisions for potential accelerated claims processing that may arise from compressed timelines.